The Oncosearch | Oncotarget

CD248: A therapeutic target in cancer and fibrotic diseases Review

Beverly A. Teicher

Published Jan 29, 2019 · Vol. 10, No. 9 · pp. 993-1009

Triplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results Research Paper

Toshiyasu Ojima, Masaki Nakamura, Mikihito Nakamori, Masahiro Katsuda, Keiji Hayata, Junya Kitadani, Shimpei Maruoka, Toshio Shimokawa, Hiroki Yamaue

Published Jan 25, 2019 · Vol. 10, No. 8 · pp. 847-855

Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles Research Paper

Harold W. Davis, Subrahmanya D. Vallabhapurapu, Zhengtao Chu, Swarajya L. Vallabhapurapu, Robert S. Franco, Michelle Mierzwa, William Kassing, William L. Barrett, Xiaoyang Qi

Published Jan 25, 2019 · Vol. 10, No. 8 · pp. 856-868

Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosis-inducing properties of human enzymes for the selective elimination of tumor cells Review

Neelakshi Mungra, Sandra Jordaan, Precious Hlongwane, Krupa Naran, Shivan Chetty, Stefan Barth

Published Jan 25, 2019 · Vol. 10, No. 8 · pp. 897-915

High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients Research Paper

Maria Bach Laursen, Linn Reinholdtz, Anna Amanda SchÃ¶nherz, Hanne Due, Ditte Starberg Jespersen, Lykke Grubach, Marianne Schmidt Ettrup, Rasmus RÃ¸ge, Steffen Falgreen, Suzette SÃ¸rensen, Julie StÃ¸ve BÃ¸dker, Alexander Schmitz, Hans E. Johnsen, Martin BÃ¸gsted, Karen DybkÃ¦r

Published Jan 22, 2019 · Vol. 10, No. 7 · pp. 717-731

Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression Research Paper

Koji Nakamura, Kenjiro Sawada, Mayuko Miyamoto, Yasuto Kinose, Akihiko Yoshimura, Kyoso Ishida, Masaki Kobayashi, Aasa Shimizu, Erika Nakatsuka, Kae Hashimoto, Seiji Mabuchi, Tadashi Kimura

Published Jan 18, 2019 · Vol. 10, No. 6 · pp. 673-683

Imbalanced sphingolipid signaling is maintained as a core proponent of a cancerous phenotype in spite of metabolic pressure and epigenetic drift Research Paper

Monique M.P. Speirs, Adam C. Swensen, Tsz Y. Chan, Peter M. Jones, John C. Holman, McCall B. Harris, John A. Maschek, James E. Cox, Richard H. Carson, Jonathon T. Hill, Joshua L. Andersen, John T. Prince, John C. Price

Published Jan 11, 2019 · Vol. 10, No. 4 · pp. 449-479

Splicing modulator FR901464 is a potential agent for colorectal cancer in combination therapy Research Paper

Tomoki Yamano, Shuji Kubo, Aya Yano, Tomoko Kominato, Shino Tanaka, Masataka Ikeda, Naohiro Tomita

Published Jan 8, 2019 · Vol. 10, No. 3 · pp. 352-367

Small molecule targeted NIR dye conjugate for imaging LHRH receptor positive cancers Research Paper

Jyoti Roy, Miranda Kaake, Philip S. Low

Published Jan 4, 2019 · Vol. 10, No. 2 · pp. 152-160

Failures in preclinical and clinical trials of c-Met inhibitors: evaluation of pathway activity as a promising selection criterion Research Paper

Veronica S. Hughes, Dietmar W. Siemann

Published Jan 4, 2019 · Vol. 10, No. 2 · pp. 184-197

We shall overcome (drug resistance) some day Editorial

Geeta G. Sharma, Luca Mologni

Published Dec 28, 2018 · Vol. 10, No. 2 · pp. 84-85

Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001 Research Paper

Cristina L. Abrahams, Xiaofan Li, Millicent Embry, Abigail Yu, Stellanie Krimm, Sarah Krueger, Nancy Y. Greenland, Kwun Wah Wen, Chris Jones, Venita DeAlmeida, Willy A. Solis, Shannon Matheny, Toni Kline, Alice Y. Yam, Ryan Stafford, Arun P. Wiita, Trevor Hallam, Mark Lupher, Arturo Molina

Published Dec 28, 2018 · Vol. 9, No. 102 · pp. 37700-37714

piRNA-8041 is downregulated in human glioblastoma and suppresses tumor growth in vitro and in vivo Research Paper

Daniel I. Jacobs, Qin Qin, Alan Fu, Zeming Chen, Jiangbing Zhou, Yong Zhu

Published Dec 28, 2018 · Vol. 9, No. 102 · pp. 37616-37626

Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer Research Paper

Karine Pozo, Stefan Zahler, Keisuke Ishimatsu, Angela M. Carter, Rahul Telange, Chunfeng Tan, Shuaijun Wang, Roswitha Pfragner, Junya Fujimoto, Elizabeth Gardner Grubbs, Masaya Takahashi, Sarah C. Oltmann, James A. Bibb

Published Dec 28, 2018 · Vol. 9, No. 102 · pp. 37662-37675

Precision medicine in the treatment stratification of AML patients: challenges and progress Review

Ines Lohse, Kurt Statz-Geary, Shaun P. Brothers, Claes Wahlestedt

Published Dec 28, 2018 · Vol. 9, No. 102 · pp. 37790-37797

Targeted therapies for advanced non-small cell lung cancer Review

Xiaojuan Ai, Xialing Guo, Jun Wang, Andreea L. Stancu, Patrick M.N. Joslin, Dianzheng Zhang, Shudong Zhu

Published Dec 25, 2018 · Vol. 9, No. 101 · pp. 37589-37607

Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer Research Paper

Takuya Shintani, Kazuma Higashisaka, Makiko Maeda, Masaya Hamada, Ryosuke Tsuji, Koudai Kurihara, Yuri Kashiwagi, Atsuhiro Sato, Masanori Obana, Ayaha Yamamoto, Keisuke Kawasaki, Ying Lin, Takashi Kijima, Yuhei Kinehara, Yoshihiro Miwa, Shinichiro Maeda, Eiichi Morii, Atsushi Kumanogoh, Yasuo Tsutsumi, Izumi Nagatomo, Yasushi Fujio

Published Dec 25, 2018 · Vol. 9, No. 101 · pp. 37520-37533

PARP inhibition prevents escape from a telomere-driven crisis and inhibits cell immortalisation Research Paper

Greg Ngo, Sam Hyatt, Julia Grimstead, Rhiannon Jones, Eric Hendrickson, Chris Pepper, Duncan Baird

Published Dec 25, 2018 · Vol. 9, No. 101 · pp. 37549-37563

MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule Research Paper

Felix Grabenbauer, Astrid Katzer, Dmitri Sisario, Simon Memmel, Michael Flentje, Vladimir L. Sukhoruko, Cholpon S. Djuzenova

Published Dec 21, 2018 · Vol. 9, No. 100 · pp. 37379-37392

Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer Research Paper

Jayati Chakrabarti, Loryn Holokai, LiJyun Syu, Nina G. Steele, Julie Chang, Jiang Wang, Syed Ahmed, Andrzej Dlugosz, Yana Zavros

Published Dec 21, 2018 · Vol. 9, No. 100 · pp. 37439-37457

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

CD248: A therapeutic target in cancer and fibrotic diseases Review

Triplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results Research Paper

Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles Research Paper

Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosis-inducing properties of human enzymes for the selective elimination of tumor cells Review

High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients Research Paper

Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression Research Paper

Imbalanced sphingolipid signaling is maintained as a core proponent of a cancerous phenotype in spite of metabolic pressure and epigenetic drift Research Paper

Splicing modulator FR901464 is a potential agent for colorectal cancer in combination therapy Research Paper

Small molecule targeted NIR dye conjugate for imaging LHRH receptor positive cancers Research Paper

Failures in preclinical and clinical trials of c-Met inhibitors: evaluation of pathway activity as a promising selection criterion Research Paper

We shall overcome (drug resistance) some day Editorial

Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001 Research Paper

piRNA-8041 is downregulated in human glioblastoma and suppresses tumor growth in vitro and in vivo Research Paper

Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer Research Paper

Precision medicine in the treatment stratification of AML patients: challenges and progress Review

Targeted therapies for advanced non-small cell lung cancer Review

Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer Research Paper

PARP inhibition prevents escape from a telomere-driven crisis and inhibits cell immortalisation Research Paper

MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule Research Paper

Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

CD248: A therapeutic target in cancer and fibrotic diseases Review

Triplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results Research Paper

Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles Research Paper

Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosis-inducing properties of human enzymes for the selective elimination of tumor cells Review

High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients Research Paper

Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression Research Paper

Imbalanced sphingolipid signaling is maintained as a core proponent of a cancerous phenotype in spite of metabolic pressure and epigenetic drift Research Paper

Splicing modulator FR901464 is a potential agent for colorectal cancer in combination therapy Research Paper

Small molecule targeted NIR dye conjugate for imaging LHRH receptor positive cancers Research Paper

Failures in preclinical and clinical trials of c-Met inhibitors: evaluation of pathway activity as a promising selection criterion Research Paper

We shall overcome (drug resistance) some day Editorial

Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001 Research Paper

piRNA-8041 is downregulated in human glioblastoma and suppresses tumor growth in vitro and in vivo Research Paper

Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer Research Paper

Precision medicine in the treatment stratification of AML patients: challenges and progress Review

Targeted therapies for advanced non-small cell lung cancer Review

Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer Research Paper

PARP inhibition prevents escape from a telomere-driven crisis and inhibits cell immortalisation Research Paper

MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule Research Paper

Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer Research Paper